Source:http://linkedlifedata.com/resource/umls/id/C1881494
NCI: An alternating, non-cross resistant regimen consisting of mechlorethamine, vincristine, prednisone and procarbazine (MOPP) followed by doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD), used for the initial treatment of Hodgkin's lymphoma.